ArticleBlood advances2022

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy.

Hridaya Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.